Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur zu Kapitel 5
Aisner J (1995) Current approach to malignant mesothelioma of the pleura. Chest 107:332S–344S
Antman KH, Corson JM, Li FP et al. (1983) Malignant mesothelioma following radiation exposure. J Clin Oncol 1:695–700
Antman KH (1981) Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 8:313–320
Antman KH, Shemin R, Ryan L et al. (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients. The Dana-Farber Cancer Institute and Brigham and Women’s Hospital experiences over two decades 1965–1985. J Clin Oncol 6:147–153
Antman KH, Pass HI, Schiff PB (2001) Management of mesothelioma. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer — principles and practice of oncology, 6th edn. Lippincott, Philadelphia, pp 1943–1969
Beauchamp KD, Kundra NK, Aranson R et al. (1992) The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura. Chest 102:1110–1112
Bischoff HG, Manegold C, Knopp M et al. (1998) Gemcitabine may reduce tumor load and tumor associated symptoms in malignant pleural mesothelioma. Proc ASCO 17:464a
Bittmann I, Wöckel W (2003) Pleuratumoren. In: Schalhorn A, Huber R (Hrsg) Manual Tumoren der Lunge und des Mediastinums. Tumorzentrum München. Zuckschwerdt, München
Bittner R, Schnoy N, Schönfeld N et al. (1995) Hochauflösende Magnetresonanztomographie (HR-MRT) von Pleura und Thoraxwand: Normalbefund und pathologische Veränderungen. Fortschr Röntgenstr 162:296–303
Boutin C, Rey F, Viallat JR (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest 108:754–758
Boutin C, Rey F (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 72:389–393
Bültzingslöwen F von (1996) Die Therapie des malignen Pleuramesothelioms. Atemw Lungenkr 22:644–653
Butchart EG, Ashcroft T, Barnsley WC et al. (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31:15–24
Byrne MJ, Davidson JA, Musk AW et al. (1999) Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol 17:25–30
Carella R, Deleonardi G, D’Errico A et al. (2001) Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis. Am J Surg Pathol 25:43–50
Churg A, Colby TV, Cagle P et al. (2000) The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24:1183–1200
Connelly RR, Spirtas R, Myers MH et al. (1987) Demographic patterns for mesothelioma in the United States. J Nat Cancer Inst 78:1053–1060
Craighead JE (1987) Current pathogenetic concepts of diffuse malignant mesothelioma. Hum Pathol 18:544–557
Crotty TB, Myers JL, Katzenstein AL, Tazelaar HD, Swensen SJ, Churg A (1994) Localized malignant mesothelioma. A clini-copathologic and flow cytometric study. Am J Surg Pathol 18:357–363
Dazzi H, Thatcher N, Hasleton PS, Chatterjee AK, Lawson RA (1990) DNA analysis by flow cytometry in malignant pleural mesothelioma: relationship to histology and survival. J Pathol 162:51–55
Dejmek A, Stromberg C, Wikstrom B, Hjerpe A (1992) Prognostic importance of the DNA ploidy pattern in malignant mesothelioma of the pleura. Anal Quant Cytol Histol 14:217–221
Dewar A, Valente M, Ring NP, Corrin B (1987) Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. J Pathol 152:309–316
El Naggar AK, Ordonez NG, Garnsey L, Batsakis JG (1991) Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study. Hum Pathol 22:972–978
Garlepp MJ, Leong CC (1995) Biological and immunological aspects of malignant mesothelioma. Eur Respir J 8:643–650
Gazdar AF, Carbone M (2003) Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 5:177–181
Goffrey MJ, Mills SE, Swanson PE, Zarbo RJ, Shah AR, Wick MR (1992) Immunoreactivity for BER-EP 4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas. Am Surg Pathol 16:593–599
Hammar SP (1993) Pleural diseases. In: Dail DH, Hammar SP (eds) Pulmonary pathology, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 1463–1579
Heelan RT, Rusch VW, Begg CB et al. (1999) Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. Am J Roentgenol 172:1039–1047
Hillerdal G (1994) Pleural plaques and risk for bronchial carcinoma and mesothelioma: a prospective study. Chest 105:144–150
Huncharek M (1994) Miliary mesothelioma. Chest 106:605
International Mesothelioma Interest Group (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 108:1122–1128
Kawashima A, Lipshitz HI (1990) Malignant pleural mesothelioma: CT manifestations in 50 cases. Am J Roentgenol 155:965–969
Kayser K et al. (2001) Glyco-and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients. J Pathol 193:175–180
Kayser K, Gabius HJ, Rahn W, Martin H, Hagemeyer O (1992) Variations of binding of labeled tumor necrosis factor alpha, epidermal growth factor, ganglioside GM-1 and N-acetylglucosamine, galactoside-specific mistletoe, lecithin and lecithin-specific antibodies in mesothelioma and metastatic adenocarcinoma of the pleura. Lung Cancer 8:185–192
Kindler HL, Meerbeck JP van (2002) The role of gemcitabine in the treatment of malignant mesothelioma. Semin Oncol 29:870–876
Klemperer P, Rabin CB (1931) Primary neoplasms of the pleura. Arch Pathol 11:385–412
Knuuttila A, Kivisaari A et al. (2001) Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma. Acta Radiol 42:502–507
Layer G, Schmitteckert H, Steudel A, Tuengerthal S, Schirren S, Kaick G van, Schild HH (1999) MRT, CT und Sonographie in der präoperativen Beurteilung der Primärtumorausdehnung beim malignen Pleuramesotheliom. Fortschr Röntgenstr 170:365–370
Leung AN, Müller NL, Miller RR (1990) CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol 154: 487–492
Maasilta P, Vehmas T, Kivisaari L, Tammiletho L, Matson K (1991) Correlations between findings at computed tomography (CT) and at thoracoscopy/thoracotomy/autopsy in pleural mesothelioma. Eur Respir J 4:952–954
Mackay B, Lukeman JM, Ordonez NG (1991) Tumors of the pleura and chest wall. Tumors of the lung. Major Probl Pathol 323–364
Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL (1998) The diagnosis of desmoplastic malignant mesothe-lioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol 110:191–199
Marom EM, Erasmus JJ, Pass HI et al. (2002) The role of imaging in malignant pleural mesothelioma. Semin Oncol 29:26–35
Mayo JR, MacKay AL, Whittal KP, Baile EM, Part PD (1995) Measurement of lung water content and pleural pressure gradient with magnetic resonance imaging. J Thorac Imaging 10:73–81
McDonald AD, McDonald JC (1980) Malignant mesothelioma in North America. Cancer 46:1650–1656
McLoud T, Flower C (1991) Imaging the pleura: sonography, CT, and MR Imaging. Am J Roentgenol 156:1145–1153
Meerbeek JP van, Baas P, Debruyne C et al. (1999) A phase II study of gemcitabine in patients with malignant pleural mesothelioma. Cancer 85:2577–2582
Metintas M, Ucgun I, Elbek O et al. (2002) Computer tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 41:1–9
Mezger J (2000) Benigne und maligne Mesotheliome. In: Wilmanns W, Huhn D, Wilms K (eds) Internistische Onkologie, 2. Aufl. Thieme, Stuttgart, S 738–742
Miller BH, Rosado-de-Christenson ML, Mason AC, Fleming MV, White CC, Krasna MJ (1996) Malignant pleural mesothelioma: radiologic-pathologic correlation. Radiographics 16:613–644
Moch H, Kiener S, Dalquen P, Gudat F (1993) Pseudomesothe-liomatous adenocarcinoma of the lung. Immunohistochemical study with special reference to detection of blood group isoantigens and Ber-EP4 antigen. Pathologe 14:11–15
Müller KM (1997) Mesothelioma. Pathology/pathogenesis/me-sothelioma register. Pneumologie 51:335–344
Neumann V, Gunthe S, Müller KM, Fischer M (2001) Malignant mesothelioma — German Mesothelioma Register 1987–1999. Int Arch Occup Environ Health 74:383–395
Ong ST, Vogelzang NJ (1996) Chemotherapy in malignant pleural mesothelioma: a review. J Clin Oncol 14:1007–1017
Patz EF, Shaffer K, Piwnica-Worms DR, Jochelson M, Sarin M, Sugarbaker DJ, Pugatch RD (1992) Malignant pleural mesothelioma: value of CT and MR imaging in predicting re-sectability. Am J Roentgenol 159:961–966
Patz EF Jr, McAdams HP, Erasmus JJ et al. (1998) Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs. doxycycline with small-bore catheter drainage. Chest 113:1305–1311
Peterson JT, Greenberg SD, Buffier PA (1984) Non-asbestos-related malignant mesothelioma: a review. Cancer 54:951–960
Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672
Pisani RJ, Colby TV, Williams DE (1988) Malignant mesothelioma of the pleura. Mayo Clin Proc 63:1234–1244
Roberts GH (1976) Distant visceral metastases in pleural mesothelioma. Br J Dis Chest 70:246–250
Ruffle P, Feld R, Minkin S et al. (1989) Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7:1157–1168
Rusch VW (1996) A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14:1–12
Ryan CW, Herndon J, Vogelzang NJ (1998) A review of chemotherapy trials for malignant mesothelioma. Chest 113: 66S–73S
Schildge J, Kaiser D, Henss H et al. (1989) Prognostic factors in diffuse malignant mesothelioma of the pleura. Pneumologie 43:660–664
Selikoff U, Hammond EC, Seidman H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46:2736–2740
Steele JP, Shamash J, Evans MT et al. (2000) Phase II study of vinorelbine in patients with malignant pleural mesothelioma. J Clin Oncol 18:3912–3918
Sugarbaker DJ, Strauss GM, Lynch TJ et al. (1993) Node status has prognostic significance in the multimodality therapy of diffuse malignant mesothelioma. J Clin Oncol 11:1172–1178.
Sugarbaker DJ, Flores R, Jacklitsch M et al. (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 117:54–65
Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53:4349–4355
Vogelzang NJ (1992) Malignant mesothelioma: diagnostic and management strategies for 1992. Semin Oncol 19:64–71
Vogelzang NJ, Rusthoven J, Paoletti P et al. (2002) Phase III single-blinded study of pemetrexed + cisplatin vs. cisplatin alone in chemonaive patients with malignant pleural mesothelioma. Proc ASCO 21:2a
Wagner JC, Sleggs CA, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in northwestern Cape Province. Br J Med 17:260–271
Wechsler RJ, Rao VM, Steiner RM (1984) The radiology of thoracic malignant mesothelioma. Crit Rev Diagn Imaging 20:283–310
Wittekind C, Meyer HJ, Bootz F (Hrsg) (2002) UICC: TNM-Klassifikation maligner Tumoren, 6. Aufl. Springer, Berlin Heidelberg New York Tokio
Wittekind C, Klimpfinger M, Sobin LH (Hrsg) (2005) TNM-At-las. Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 5. Aufl. Springer, Berlin Heidelberg New York Tokio
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Layer, G. (2006). Malignes Pleuramesotheliom. In: Layer, G., van Kaick, G., Delorme, S. (eds) Radiologische Diagnostik in der Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33565-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-33565-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-66991-3
Online ISBN: 978-3-540-33565-8
eBook Packages: Medicine (German Language)